This would support a hypothesis that polymorphisms leading to a decrease in PFKFB3 expression may be protective from the development of obesity; however, tissue-specific transcriptional studies in humans would be required to fully support this assertion. The gene discussed is PFKFB3; the disease is obesity due to melanocortin 4 receptor deficiency.